Stay updated on Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page
- Check4 days agoChange DetectedBladder cancer and a MedlinePlus Genetics entry have been added to the related topics section, linking the study to condition-specific information and genetics resources. This enhances navigational context for users exploring the trial.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous v3.6.4; this indicates a minor version update with no apparent changes to the displayed content.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a software/content update to the ClinicalTrials.gov page without changes to the study details.SummaryDifference0.1%

- Check61 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.3, indicating a newer version of the page template or rendering. This change is a metadata/version update and does not modify the study’s content or user-facing details.SummaryDifference0.1%

- Check75 days agoChange DetectedNew help/navigation sections were added to the page—How to Read a Study Record, Common Questions, How to Join a Study—and the Intervention/Treatment header appears, replacing the previous Intervention / Treatment heading. The page revision tag was updated to v3.6.0 (from v3.5.5).SummaryDifference0.5%

- Check82 days agoChange DetectedRevision: v3.5.5 was applied, updating the page from v3.5.4. This is a minor revision that does not change the study details or other substantive content on the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.